C-271

N/A

Report date: 2025/07/14 16:29:11
NME

Base Information

Drug NameC-271
Drug Alias NameC-271
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG/T mismatch-specific thymine DNA glycosylase inhibitors
TargetsG/T mismatch-specific thymine DNA glycosylase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCytosinLab Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCytosinLab Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A